![Strategies in the prevention of ventilator-associated pneumonia - Diego J. Maselli, Marcos I. Restrepo, 2011 Strategies in the prevention of ventilator-associated pneumonia - Diego J. Maselli, Marcos I. Restrepo, 2011](https://journals.sagepub.com/cms/10.1177/1753465810395655/asset/images/large/10.1177_1753465810395655-fig1.jpeg)
Strategies in the prevention of ventilator-associated pneumonia - Diego J. Maselli, Marcos I. Restrepo, 2011
![Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13613-020-00775-4/MediaObjects/13613_2020_775_Fig1_HTML.png)
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text
![Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia | Semantic Scholar Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/845229d59ccfe8a7b980065609f13555787a7bd8/2-Figure1-1.png)
Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia | Semantic Scholar
![The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care](https://rc.rcjournal.com/content/respcare/60/10/1495/F3.large.jpg)
The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
![Clinical Practice Guideline: Evaluation and Initial Management of Hospital- Acquired and Ventilator-Associated Pneumonia (HAP/VAP) - Tech License Express Clinical Practice Guideline: Evaluation and Initial Management of Hospital- Acquired and Ventilator-Associated Pneumonia (HAP/VAP) - Tech License Express](https://techlicenseexpress.com/system/spree/screenshots/screenshots/000/000/493/large/Screen_Shot_2020-05-17_at_15.54.52.png?1589745343)
Clinical Practice Guideline: Evaluation and Initial Management of Hospital- Acquired and Ventilator-Associated Pneumonia (HAP/VAP) - Tech License Express
![The clinical diagnostic strategies of ventilator-associated pneumonia. | Download Scientific Diagram The clinical diagnostic strategies of ventilator-associated pneumonia. | Download Scientific Diagram](https://www.researchgate.net/publication/332059189/figure/fig1/AS:741486459109377@1553795556210/The-clinical-diagnostic-strategies-of-ventilator-associated-pneumonia.png)
The clinical diagnostic strategies of ventilator-associated pneumonia. | Download Scientific Diagram
![Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/e84ec235-3c00-46fd-acab-0ae17ae0fc6d/gr1.gif)
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine
![Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-08307-9/MediaObjects/41598_2022_8307_Fig1_HTML.png)
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports
![Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia | Semantic Scholar Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/845229d59ccfe8a7b980065609f13555787a7bd8/6-Figure2-1.png)